Medicare Program; Meeting of the Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End-Stage Renal Disease Services-July 14 Through July 15, 2005, 36642 [05-12523]
Download as PDF
36642
Federal Register / Vol. 70, No. 121 / Friday, June 24, 2005 / Notices
Centers for Medicare & Medicaid
Services
[CMS–5033–N5]
Medicare Program; Meeting of the
Advisory Board on the Demonstration
of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal
Disease Services—July 14 Through
July 15, 2005
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
third public meeting of the Advisory
Board on the Demonstration of a
Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease
(ESRD) Services. Notice of this meeting
is required by the Federal Advisory
Committee Act (5 U.S.C. App. 2, section
10(a)(1) and (a)(2)). The Advisory Board
will provide advice and
recommendations with respect to the
establishment and operation of the
demonstration mandated by section
623(e) of the Medicare Prescription
Drug, Improvement, and Modernization
Act of 2003.
DATES: The meeting is on Thursday, July
14, 2005, from 9 a.m. to 5 p.m., eastern
standard time and Friday, July 15, 2005,
from 9 a.m. to 3 p.m. eastern standard
time.
Special Accomodations: Persons
attending the meeting, who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to notify Pamela Morrow by July
7, 2005, by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or by
telephone at (410) 786–2461.
ADDRESSES: The meeting will be held at
the Marriott Hotel—BWI Airport, 1743
West Nursery Rd., Baltimore, MD 21240.
Attendance is limited to the space
available, so seating will be on a first
come, first served basis.
Web site: Up-to-date information on
this meeting is located at https://
www.cms.hhs.gov/faca/esrd.
Hotline: Up-to-date information on
this meeting is located on the CMS
Advisory Committee Hotline at 1 (877)
449–5659 (toll free) or in the Baltimore
area at (410) 786–9379.
FOR FURTHER INFORMATION CONTACT:
Pamela Morrow by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or
telephone at (410) 786–2461.
VerDate jul<14>2003
19:06 Jun 23, 2005
Jkt 205001
On June 2,
2004, we published a Federal Register
notice requesting nominations for
individuals to serve on the Advisory
Board on the Demonstration of a
Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease
(ESRD) Services. The June 2, 2004,
notice also announced the
establishment of the Advisory Board
and the signing by the Secretary on May
11, 2004, of the charter establishing the
Advisory Board. On January 28, 2005,
we published a Federal Register notice
announcing the appointment of eleven
individuals to serve as members of the
Advisory Board on the Demonstration of
a Bundled Case-Mix Adjusted Payment
System for ESRD Services, including
one individual to serve as cochairperson, and one additional cochairperson, who is employed by CMS.
The first public meeting of the Advisory
Board was held on February 16, 2005.
The second public meeting of the
Advisory Board was held on May 24,
2005. This notice announces the third
public meeting of this Advisory Board.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
I. Topics of the Advisory Board Meeting
The Advisory Board on the
Demonstration of a Bundled Case-Mix
Adjusted Payment System for ESRD
Services will study and make
recommendations on the following
issues:
• The drugs, biologicals, and clinical
laboratory tests to be bundled into the
demonstration payment rates.
• The method and approach to be
used for the patient characteristics to be
included in the fully case-mix adjusted
demonstration payment system.
• The manner in which payment for
bundled services provided by nondemonstration providers should be
handled for beneficiaries participating
in the demonstration.
• The feasibility of providing
financial incentives and penalties to
organizations operating under the
demonstration that meet or fail to meet
applicable quality standards.
• The specific quality standards to be
used.
• The feasibility of using disease
management techniques to improve
quality and patient satisfaction and
reduce costs of care for the beneficiaries
participating in the demonstration.
• The selection criteria for
demonstration organizations.
II. Procedure and Agenda of the
Advisory Board Meeting
This meeting is open to the public.
The Advisory Board will hear
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
background presentations from CMS.
The Advisory Board will then deliberate
openly on the general topic and will
make recommendations on specific
topics for future meetings. The Advisory
Board will also allow at least a 30minute open public session. Interested
parties may speak or ask questions
during the public comment period.
Comments may be limited by the time
available. Written questions should be
submitted by July 7, 2005, to
ESRDAdvisoryBoard@cms.hhs.gov.
Parties may also submit written
comments following the meeting to the
contact listed under the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program)
Dated: June 16, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–12523 Filed 6–23–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Adoption and Foster Care Analysis
and Reporting System for Title IV–B
and Title IV–E
OMB No.: 0980–0267.
Description: Section 479 of title IV–E
of the Social Security Act directs States
to establish and implement an adoption
and foster care reporting system. The
data are used for a number of reasons,
including responding to Congressional
requests for current data on children in
foster care or those who have been
adopted; responding to questions and
requests from other Federal departments
and agencies; trend analyses and shortand long-term planning; targeting areas
for greater or potential technical
assistance efforts; and determining and
assessing outcomes for children and
families.
Respondents: States, the District of
Columbia and Puerto Rico.
E:\FR\FM\24JNN1.SGM
24JNN1
Agencies
[Federal Register Volume 70, Number 121 (Friday, June 24, 2005)]
[Notices]
[Page 36642]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12523]
[[Page 36642]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-5033-N5]
Medicare Program; Meeting of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for End-
Stage Renal Disease Services--July 14 Through July 15, 2005
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the third public meeting of the Advisory
Board on the Demonstration of a Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease (ESRD) Services. Notice of this
meeting is required by the Federal Advisory Committee Act (5 U.S.C.
App. 2, section 10(a)(1) and (a)(2)). The Advisory Board will provide
advice and recommendations with respect to the establishment and
operation of the demonstration mandated by section 623(e) of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
DATES: The meeting is on Thursday, July 14, 2005, from 9 a.m. to 5
p.m., eastern standard time and Friday, July 15, 2005, from 9 a.m. to 3
p.m. eastern standard time.
Special Accomodations: Persons attending the meeting, who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify Pamela Morrow by July
7, 2005, by e-mail at ESRDAdvisoryBoard@cms.hhs.gov or by telephone at
(410) 786-2461.
ADDRESSES: The meeting will be held at the Marriott Hotel--BWI Airport,
1743 West Nursery Rd., Baltimore, MD 21240. Attendance is limited to
the space available, so seating will be on a first come, first served
basis.
Web site: Up-to-date information on this meeting is located at
https://www.cms.hhs.gov/faca/esrd.
Hotline: Up-to-date information on this meeting is located on the
CMS Advisory Committee Hotline at 1 (877) 449-5659 (toll free) or in
the Baltimore area at (410) 786-9379.
FOR FURTHER INFORMATION CONTACT: Pamela Morrow by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or telephone at (410) 786-2461.
SUPPLEMENTARY INFORMATION: On June 2, 2004, we published a Federal
Register notice requesting nominations for individuals to serve on the
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal Disease (ESRD) Services. The June 2,
2004, notice also announced the establishment of the Advisory Board and
the signing by the Secretary on May 11, 2004, of the charter
establishing the Advisory Board. On January 28, 2005, we published a
Federal Register notice announcing the appointment of eleven
individuals to serve as members of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for ESRD
Services, including one individual to serve as co-chairperson, and one
additional co-chairperson, who is employed by CMS. The first public
meeting of the Advisory Board was held on February 16, 2005. The second
public meeting of the Advisory Board was held on May 24, 2005. This
notice announces the third public meeting of this Advisory Board.
I. Topics of the Advisory Board Meeting
The Advisory Board on the Demonstration of a Bundled Case-Mix
Adjusted Payment System for ESRD Services will study and make
recommendations on the following issues:
The drugs, biologicals, and clinical laboratory tests to
be bundled into the demonstration payment rates.
The method and approach to be used for the patient
characteristics to be included in the fully case-mix adjusted
demonstration payment system.
The manner in which payment for bundled services provided
by non-demonstration providers should be handled for beneficiaries
participating in the demonstration.
The feasibility of providing financial incentives and
penalties to organizations operating under the demonstration that meet
or fail to meet applicable quality standards.
The specific quality standards to be used.
The feasibility of using disease management techniques to
improve quality and patient satisfaction and reduce costs of care for
the beneficiaries participating in the demonstration.
The selection criteria for demonstration organizations.
II. Procedure and Agenda of the Advisory Board Meeting
This meeting is open to the public. The Advisory Board will hear
background presentations from CMS. The Advisory Board will then
deliberate openly on the general topic and will make recommendations on
specific topics for future meetings. The Advisory Board will also allow
at least a 30-minute open public session. Interested parties may speak
or ask questions during the public comment period. Comments may be
limited by the time available. Written questions should be submitted by
July 7, 2005, to ESRDAdvisoryBoard@cms.hhs.gov. Parties may also submit
written comments following the meeting to the contact listed under the
FOR FURTHER INFORMATION CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: June 16, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-12523 Filed 6-23-05; 8:45 am]
BILLING CODE 4120-01-P